Bioventus Inc. (BVS)
NASDAQ: BVS · Real-Time Price · USD
9.25
+0.41 (4.64%)
Apr 8, 2026, 12:42 PM EDT - Market open
Bioventus Market Cap
Bioventus has a market cap or net worth of $769.18 million as of April 8, 2026. Its market cap has increased by 20.48% in one year.
Market Cap
769.18M
Enterprise Value
995.20M
1-Year Change
20.48%
Ranking
Category
Stock Price
$9.25
Market Cap Chart
Since the IPO on February 11, 2021, Bioventus's market cap has increased from $713.47M to $769.18M, an increase of 7.81%. That is a compound annual growth rate of 1.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 7, 2026 | 595.53M | 19.51% |
| Dec 31, 2025 | 498.30M | -27.40% |
| Dec 31, 2024 | 686.36M | 106.84% |
| Dec 29, 2023 | 331.83M | 105.22% |
| Dec 30, 2022 | 161.69M | -81.23% |
| Dec 31, 2021 | 861.26M | 20.71% |
| Feb 11, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CONMED | 1.05B |
| SS Innovations International | 961.71M |
| InMode | 868.65M |
| Lumexa Imaging Holdings | 859.22M |
| Integra LifeSciences Holdings | 725.60M |
| CeriBell | 683.94M |
| Avanos Medical | 643.20M |
| SI-BONE | 583.42M |